STERIS (NYSE: STE) — Perfil da empresa, notícias e dados financeiros
STERIS focuses on infection prevention products and services for healthcare and life sciences, enhancing patient safety.

STERIS
STERIS is a provider of products and services that support patient care, with a focus on infection prevention, sterilization, and surgical technologies. The company operates through core segments including Healthcare, Applied Sterilization Technologies, and Life Sciences. Its offerings include capital equipment such as sterilizers, surgical tables, and operating room integration systems, along with consumable products, instrument repair, and contract sterilization services using gamma, electron beam, and ethylene oxide methods. Headquartered in Ireland with major operations in Mentor, Ohio, STERIS serves hospitals, surgery centers, medical device manufacturers, and pharmaceutical companies globally.
Resumo
Operações
Produtos e/ou serviços de STERIS
- Healthcare Sterilization Equipment and Consumables: Capital equipment including steam sterilizers, vaporized hydrogen peroxide sterilizers, glassware washers, surgical tables, operating room lighting, and endoscopy reprocessing equipment, alongside infection prevention consumables and sterility assurance products for surgical facilities.
- Contract Sterilization Services: Contract processing services for medical device and pharmaceutical manufacturers, utilizing a global network of facilities offering gamma irradiation, electron beam irradiation, X-ray irradiation, ethylene oxide gas processing, and vaporized hydrogen peroxide technologies.
- Surgical Instrument Repair and Maintenance: Onsite and offsite maintenance, repair, and reprocessing services for surgical instruments, endoscopy devices, and capital equipment, supported by dedicated service training centers, offsite reprocessing centers, and extensive replacement parts distribution channels.
- Life Sciences Contamination Control: Washing, sterilization, biodecontamination, and water purification equipment, together with specialized cleaning chemistries, surface disinfectants, cleanroom alcohols, and sterility assurance barriers designed for biotechnology, pharmaceutical manufacturing, and research laboratories.
- Operating Room Solutions and Integration: Operating room integration systems, surgical lights, equipment management columns, and process improvement consulting services designed to optimize workflow efficiency, safety, and infection control compliance in hospital operating rooms and outpatient surgery centers.
- Laboratory Testing and Validation Services: Laboratory testing services, microcontamination testing, material compatibility assessments, and sterilization process validation provided to pharmaceutical, biotechnology, and medical device manufacturers across facilities in North America, Europe, and Asia-Pacific.
equipe executiva do STERIS
- Daniel A. CarestioPresident, CEO & Director
- Karen L. BurtonSenior VP, CFO & Chief Accounting Officer
- John Adam ZangerleSenior VP, General Counsel & Secretary
- Mary Clare FraserSVP & Chief Human Resources Officer
- Cary L. MajorsSenior VP & President of Healthcare
- Julie WinterVice President of Investor Relations & Corporate Communications
- Lindsey McGowanVP, Chief Compliance & Quality Officer
- Julia K. MadsenSenior VP & GM of Life Sciences
- Andrew XilasSenior VP & GM of Dental
- Kenneth E. KohlerSenior VP & GM of AST
Últimas notícias sobre a STERIS
Histórico de dividendos
Dividendos por ação pagos pela STERIS , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | — | — | — | $1.3200 |
| FY2026 | — | — | — | $2.4600 |
| FY2025 | — | — | — | $2.2300 |
| FY2024 | — | — | — | $2.0300 |
| FY2023 | — | — | — | $1.8400 |
Principais indicadores financeiros
Resultados divulgados pela STERIS , em USD.
- Cap. de mercado
- 22,3 bi
- Receita (TTM)
- 6 bi
- P/L
- 27.9
- LPA (diluído, TTM)
- 8.2
- Dividend yield
- 1.1%
- Margem de lucro
- 13.3%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 5,9 bi | 1,1 bi | 785,1 mi | |
| 5,5 bi | 866,6 mi | 614,6 mi | |
| 5,1 bi | 836,1 mi | 378,2 mi | |
| 4,5 bi | 791,1 mi | 107 mi |